Arvind Trindade, MD

Dr. Trindade is an advanced endoscopist with a specialty in Barrett’s esophagus screening, Barrett’s endotherapy, and advanced imaging, with experience leading a high-volume referral program and nationally recognized research for the treatment of this condition. As an advanced endoscopist he performs complex pancreaticobiliary procedures such as ERCP, interventional EUS, luminal stenting, and complex polyp removal.

Dr. Trindade’s primary research focus in Barrett’s esophagus, the main risk factor to esophageal adenocarcinoma (EAC), is exploring ways to improve screening for Barrett’s and early EAC. This includes novel ways to identify patients at risk, and research in non-endoscopic minimally invasive devices. Dr. Trindade also performs research in novel ablation devices for Barrett’s, as well as advanced imaging in Barrett’s to find precancerous cells (dysplasia) that is focal and often hard to locate in the esophagus. He published more than 50 articles in Barrett’s esophagus in various high impact factor journals, participated in many multicenter Barrett’s clinical trials, and is a sought-after speaker on the topic internationally.

As a result of Dr. Trindade’s work in the field, he recently participated in the American Gastrological Association (AGA) Barrett’s esophagus clinical practice update/guideline. He has also contributed editorials on Barrett’s esophagus topics in two prestigious journals in this field (Clinical Gastroenterology and Hepatology and Endoscopy). He is passionate about the field of Barrett’s esophagus and dedicated to advancing knowledge that will help lower the incidence of esophageal adenocarcinoma.

Philosophy of Care:

I treat every patient as if they are a family member and try my best to provide exceptional gastrointestinal and endoscopic care.